Eisei Shin

625 total citations
30 papers, 485 citations indexed

About

Eisei Shin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Eisei Shin has authored 30 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Eisei Shin's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Eisei Shin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Eisei Shin collaborates with scholars based in Japan, United Kingdom and South Korea. Eisei Shin's co-authors include Shoichi Fujita, Shin‐ichiro Takai, Isamu Nishisho, Akihiro Miya, Ikuo Yana, Tetsuro Kobayashi, Takesada Mori, Tetsuro Kobayashi, Takesada Mori and Tadashi Kobayashi and has published in prestigious journals such as Journal of Hepatology, Genes Chromosomes and Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Eisei Shin

28 papers receiving 472 citations

Peers

Countries citing papers authored by Eisei Shin

Since Specialization

Citations

This map shows the geographic impact of Eisei Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisei Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisei Shin more than expected).

Fields of papers citing papers by Eisei Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisei Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisei Shin. The network helps show where Eisei Shin may publish in the future.

Co-authorship network of co-authors of Eisei Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Eisei Shin. A scholar is included among the top collaborators of Eisei Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eisei Shin. Eisei Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study 2023 ·International Journal of Clinical Oncology ·Hiroyuki Nishiyama, Toyonori Tsuzuki, Chikara Οhyama, Hideyasu Matsuyama, (unknown), Yuko Hayashi, Nobuya Hayashi, (unknown), Eisei Shin, Osamu Ogawa	2
2	Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study 2020 ·Cancer Medicine ·Hidehito Horinouchi, Shinji Atagi, Satoshi Oizumi, Kadoaki Ohashi, Tomohiro Kato, Toshiyuki Kozuki, Masahiro Seike, Takashi Sone, Tomotaka Sobue, Takaaki Tokito, Hideyuki Harada, Tadashi Maeda, Tadashi Mio, (unknown), (unknown), Eisei Shin, Haruyasu Murakami	31
3	Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer 2015 ·Breast Cancer ·Shinzaburo Noguchi, Hee Jeong Kim, (unknown), Vani Parmar, Nobuaki Sato, Hwei-Chung Wang, (unknown), (unknown), (unknown), Y. Itoh, Eisei Shin	26
4	Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer 2014 ·Investigational New Drugs ·Takayasu Kurata, Junji Tsurutani, Yasuhito Fujisaka, Wataru Okamoto, Hidetoshi Hayashi, Hisato Kawakami, Eisei Shin, Nobuya Hayashi, Kazuhiko Nakagawa	9
5	261 VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PREDICTOR OF RESPONSE TO THE COMBINED THERAPY WITH SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 2013 ·Journal of Hepatology ·(unknown), (unknown), (unknown), (unknown), Eisei Shin, Ju Hyun Shim, (unknown), (unknown), (unknown), Sunghyun Bae, (unknown), SeongShick Ryu, (unknown)	1
6	Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors 2009 ·Cancer Chemotherapy and Pharmacology ·Noboru Yamamoto, Tomohide Tamura, Nobuyuki Yamamoto, Kazuhiko Yamada, Yasuhide Yamada, Hiroshi Nokihara, Yutaka Fujiwara, Toshiaki Takahashi, Haruyasu Murakami, Narikazu Boku, Kentaro Yamazaki, Thomas A. Puchalski, Eisei Shin	42
7	Preliminary result of accelerated partial breast irradiation after breast-conserving surgery 2008 ·Breast Cancer ·Ken Yoshida, Takayuki Nose, Norikazu Masuda, Hideya Yamazaki, Tadayuki Kotsuma, (unknown), Jun Yamamura, Hiroko Masuda, Eisei Shin, (unknown), Yoshifumi Komoike, (unknown), Masashi Takeda, Keiko Kuriyama	16
8	Late Phase II Clinical Study of Vinorelbine Monotherapy in Advanced or Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes 2005 ·Japanese Journal of Clinical Oncology ·Masakazu Toi, Toshiaki Saeki, Kenjiro Aogi, Muneaki Sano, Kiyohiko Hatake, Taro Asaga, Yutaka Tokuda, Shoshu Mitsuyama, Morihiko Kimura, Tadashi Kobayashi, (unknown), Toshio Tabei, Eisei Shin, Reiki Nishimura, Shinji Ohno, Shigemitsu Takashima	29
9	Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer 2002 ·Cancer Chemotherapy and Pharmacology ·Gyo Asai, Nobuyuki Yamamoto, Masakazu Toi, Eisei Shin, Kiyoshi Nishiyama, (unknown), Yasuo Nomura, Shigemitsu Takashima, Morihiko Kimura, Takeshi Tominaga	13
10	New Technique of Laparoscopic-Assisted Excision of a Cholecystocolic Fistula: Report of a Case 2001 ·Surgery Today ·Kazumasa Fujitani, Yasunori Hasuike, Toshimasa Tsujinaka, Hideyuki Mishima, (unknown), Eisei Shin, (unknown), (unknown), (unknown)	18
11	[Efficacy and side effect of continuous intra-arterial infusion of high-dose 5-FU for liver metastases of colorectal cancer]. 1999 ·PubMed ·(unknown), Yasunori Hasuike, (unknown), (unknown), Kazumasa Fujitani, Eisei Shin, (unknown), (unknown), Isamu Nishisho, Koji Kobayashi, Toshiyuki Kobayashi, Naoko Kikkawa	5
12	Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis. 1998 ·PubMed ·Seung Jin Kim, Eisuke Shiba, Tadashi Kobayashi, (unknown), Jun‐ichi Furukawa, Y Takatsuka, Eisei Shin, Hidenori Koyama, Hideo Inaji, Shinji Takai	48
13	Expression of p16 and Cyclin-Dependent Kinase 4 Proteins in Primary Breast Carcinomas 1997 ·Oncology ·Yasuhiro Ito, Tetsuro Kobayashi, Tsutomu Takeda, Yoshiaki Nakano, Yasuhiro Tamaki, Yoshifumi Komoike, (unknown), Eisei Shin, Yuichi Takatsuka, Nobuteru Kikkawa, Nariaki Matsuura∥, Morito Monden	6
14	A Case of Hepatic Hemangiosarcoma Associated with Kasabach-Merritt Syndrome. 1996 ·The Japanese Journal of Gastroenterological Surgery ·(unknown), Takeshi Tono, Hidewaki Nakagawa, Kazuhiro Fukuda, Eisei Shin, Hideyuki Mishima, (unknown), Kenji Kobayashi, Tetsuro Kobayashi, Nobuteru Kikkawa	1
15	The Significance of Second Hepatectomy for Recurrent Metastases from Colorectal Primaries. 1995 ·The Japanese Journal of Gastroenterological Surgery ·Takeshi Tono, Nobuteru Kikkawa, (unknown), Hideyuki Mishima, Yasuhiro Tamaki, Eisei Shin, Kenji Kobayashi, Yuichi Takatsuka	2
16	Deletion Mapping of Chromosome 1p and 22q in Pheochromocytoma 1993 ·Japanese Journal of Cancer Research ·Eisei Shin, Shoichi Fujita, Koji Takami, Hiroki Kurahashi, (unknown), Tetsuro Kobayashi, Takesada Mori, Isamu Nishisho, Shin‐ichiro Takai	45
17	Construction of radiation-reduced hybrids and their use in mapping of microclones from chromosome 10p11.2-q11.2 1993 ·The Japanese Journal of Human Genetics ·Shoichi Fujita, Eisei Shin, Tsutomu Nakamura, Hiroki Kurahashi, Yasufumi Kaneda, Kiyoji Tanaka, Takesada Mori, Shin‐ichiro Takai, Isamu Nishisho	1
18	p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid Carcinomas 1992 ·Japanese Journal of Cancer Research ·(unknown), Ikuo Yana, Tetsuro Kobayashi, Eisei Shin, (unknown), Shoichi Fujita, Akihiro Miya, Takesada Mori, Isamu Nishisho, Shin‐ichiro Takai	115
19	Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma 1992 ·Genes Chromosomes and Cancer ·(unknown), Isamu Nishisho, Masayuki Yamamoto, Akihiro Miya, Eisei Shin, (unknown), Shoichi Fujita, Tetsuro Kobayashi, Guy A. Rouleau, Takesada Mori, Shin‐ichiro Takai	34
20	Tight Linkage of the <italic>ret</italic> Proto-oncogene with the Multiple Endocrine Neoplasia Type 2A Locus 1991 ·Japanese Journal of Clinical Oncology ·(unknown), Tetsuro Miki, (unknown), Akihiro Miya, Eisei Shin, (unknown), Tetsuro Kobayashi, Tomoko Tahira, Yukihito Ishizaka, Fumio Itoh, Minako Nagao, Takesada Mori, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact